Article
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.
Diabetologia - 1 Feb 2024
Meulebrouck Sarah, Scherrer Victoria, Boutry Raphaël, Toussaint Bénédicte, Vaillant Emmanuel, Dechaume Aurélie, Loiselle Hélène, Balkau Beverley, Charpentier Guillaume, Franc Sylvia, Marre Michel, Baron Morgane, Vaxillaire Martine, Derhourhi Mehdi, Boissel Mathilde, Froguel Philippe, Bonnefond Amélie
Abstract excerpt
AIMS/HYPOTHESIS: GLIS3 encodes a transcription factor involved in pancreatic beta cell development and function. Rare pathogenic, bi-allelic mutations in GLIS3 cause syndromic neonatal diabetes whereas frequent SNPs at this locus associate with common type 2 diabetes risk. Because rare, functional variants located in other susceptibility genes for type 2 diabetes have already been shown to strongly increase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
